Skip to main content
Equibles

STEMPOINT CAPITAL LP

Position in GPCR — Structure Therapeutics Inc.

CIK 1952142 NEW YORK, NY
Back to GPCR Full portfolio

Position in GPCR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,049,013
-$7,603,856 QoQ
Shares Held
38,178
-80.9% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#88
of 190 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 86% Shared 0% None 14%

Common Shares in GPCR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STEMPOINT CAPITAL LP holds $524,439,182 across 65 Biotechnology names. GPCR ranks #57 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TNGX
Tango Therapeutics, Inc.
 1,223,019 $38,231,573
2 ABVX
Abivax S.A.
 283,657 $37,800,131
3 RVMD
Revolution Medicines, Inc.
 159,943 $29,954,125
4 ERAS
Erasca, Inc.
 1,565,913 $28,687,526
5 TYRA
Tyra Biosciences, Inc.
 632,754 $20,210,162
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 200,851 $19,578,955
7 ELVN
Enliven Therapeutics, Inc.
 346,914 $17,605,885
8 MLYS
Mineralys Therapeutics, Inc.
 602,686 $16,260,468

All Filings in GPCR

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,049,013 38,178
2026-03-31 $9,652,869 200,267
2025-12-31 $24,417,127 351,073
2025-09-30 $3,621,380 129,335